Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

NTRK1 fusion in glioblastoma multiforme.

Kim J, Lee Y, Cho HJ, Lee YE, An J, Cho GH, Ko YH, Joo KM, Nam DH.

PLoS One. 2014 Mar 19;9(3):e91940. doi: 10.1371/journal.pone.0091940. eCollection 2014. Erratum in: PLoS One. 2014;9(6):e101140. Cho, Hee-Jin [corrected to Cho, Hee Jin].

2.

NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.

Park DY, Choi C, Shin E, Lee JH, Kwon CH, Jo HJ, Kim HR, Kim HS, Oh N, Lee JS, Park OK, Park E, Park J, Shin JY, Kim JI, Seo JS, Park HD, Park J.

Oncotarget. 2016 Feb 16;7(7):8399-412. doi: 10.18632/oncotarget.6724.

3.

Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.

Oelmann E, Sreter L, Schuller I, Serve H, Koenigsmann M, Wiedenmann B, Oberberg D, Reufi B, Thiel E, Berdel WE.

Cancer Res. 1995 May 15;55(10):2212-9.

4.

Transforming fusions of FGFR and TACC genes in human glioblastoma.

Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, Castano A, Liu EM, Reichel J, Porrati P, Pellegatta S, Qiu K, Gao Z, Ceccarelli M, Riccardi R, Brat DJ, Guha A, Aldape K, Golfinos JG, Zagzag D, Mikkelsen T, Finocchiaro G, Lasorella A, Rabadan R, Iavarone A.

Science. 2012 Sep 7;337(6099):1231-5. doi: 10.1126/science.1220834. Epub 2012 Jul 26.

5.

Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma.

Créancier L, Vandenberghe I, Gomes B, Dejean C, Blanchet JC, Meilleroux J, Guimbaud R, Selves J, Kruczynski A.

Cancer Lett. 2015 Aug 28;365(1):107-11. doi: 10.1016/j.canlet.2015.05.013. Epub 2015 May 19.

PMID:
26001971
6.

LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.

Dai HP, Xue YQ, Zhou JW, Li AP, Wu YF, Pan JL, Wang Y, Zhang J.

Genes Chromosomes Cancer. 2009 Dec;48(12):1027-36. doi: 10.1002/gcc.20704.

PMID:
19760607
7.

The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.

Greco A, Mariani C, Miranda C, Lupas A, Pagliardini S, Pomati M, Pierotti MA.

Mol Cell Biol. 1995 Nov;15(11):6118-27.

8.

Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21).

Charest A, Lane K, McMahon K, Park J, Preisinger E, Conroy H, Housman D.

Genes Chromosomes Cancer. 2003 May;37(1):58-71.

PMID:
12661006
9.

Functional characterization of NTRK1 mutations identified in melanoma.

Miranda C, Mazzoni M, Sensi M, Pierotti MA, Greco A.

Genes Chromosomes Cancer. 2014 Oct;53(10):875-80. doi: 10.1002/gcc.22200. Epub 2014 Jun 26.

PMID:
24965840
10.

A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.

Butti MG, Bongarzone I, Ferraresi G, Mondellini P, Borrello MG, Pierotti MA.

Genomics. 1995 Jul 1;28(1):15-24.

PMID:
7590742
11.

Investigation of neurotrophic tyrosine kinase receptor 1 fusions and neurotrophic tyrosine kinase receptor family expression in non-small-cell lung cancer and sensitivity to AZD7451 in vitro.

Tatematsu T, Sasaki H, Shimizu S, Okuda K, Shitara M, Hikosaka Y, Moriyama S, Yano M, Brown J, Fujii Y.

Mol Clin Oncol. 2014 Sep;2(5):725-730. Epub 2014 Jun 19.

13.

Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through TrkA and requires the common neurotrophin receptor P75.

Culmsee C, Gerling N, Lehmann M, Nikolova-Karakashian M, Prehn JH, Mattson MP, Krieglstein J.

Neuroscience. 2002;115(4):1089-108.

PMID:
12453482
14.

Gain of function mutations of RTK conserved residues display differential effects on NTRK1 kinase activity.

Miranda C, Zanotti G, Pagliardini S, Ponzetto C, Pierotti MA, Greco A.

Oncogene. 2002 Nov 28;21(54):8334-9.

15.

ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.

Charest A, Wilker EW, McLaughlin ME, Lane K, Gowda R, Coven S, McMahon K, Kovach S, Feng Y, Yaffe MB, Jacks T, Housman D.

Cancer Res. 2006 Aug 1;66(15):7473-81.

16.

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.

Vaishnavi A, Capelletti M, Le AT, Kako S, Butaney M, Ercan D, Mahale S, Davies KD, Aisner DL, Pilling AB, Berge EM, Kim J, Sasaki H, Park S, Kryukov G, Garraway LA, Hammerman PS, Haas J, Andrews SW, Lipson D, Stephens PJ, Miller VA, Varella-Garcia M, Jänne PA, Doebele RC.

Nat Med. 2013 Nov;19(11):1469-1472. doi: 10.1038/nm.3352. Epub 2013 Oct 27.

17.

Rearrangements of NTRK1 gene in papillary thyroid carcinoma.

Greco A, Miranda C, Pierotti MA.

Mol Cell Endocrinol. 2010 May 28;321(1):44-9. doi: 10.1016/j.mce.2009.10.009. Epub 2009 Oct 31. Review.

PMID:
19883730
18.

Neurobiology of pain, interoception and emotional response: lessons from nerve growth factor-dependent neurons.

Indo Y.

Eur J Neurosci. 2014 Feb;39(3):375-91. doi: 10.1111/ejn.12448. Review.

PMID:
24494678
19.
20.

Oncogenic rearrangements of the NTRK1/NGF receptor.

Pierotti MA, Greco A.

Cancer Lett. 2006 Jan 28;232(1):90-8. Epub 2005 Oct 20. Review.

PMID:
16242838

Supplemental Content

Support Center